Mersana Therapeutics (NASDAQ: MRSN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Mersana Therapeutics (NASDAQ: MRSN) through any online brokerage.
The latest price target for Mersana Therapeutics (NASDAQ: MRSN) was reported by SVB Leerink on Monday, May 9, 2022. The analyst firm set a price target for 14.00 expecting MRSN to rise to within 12 months (a possible 202.38% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $4.63 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Mersana Therapeutics.
Mersana Therapeutics’s Q2 earnings are confirmed for Friday, August 5, 2022.
There is no upcoming split for Mersana Therapeutics.
Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.